morphonorconic
Bluelighter
Yeah, hey sorry OP, didn't mean to hijack the thread, but it has spawned an interesting conversation nevertheless.
Cane-No problem, anytime. Glad I could help.
Alright, as far as the use of Mixed Agonist Antagonist Opioids for long term maintenence, I still feel that there could be an advantage to their use as opposed to full agonists. The key lies in selectivity, and favorable mu:kappa/sigma ratios. With what I know of Pentazocine and Cyclazocine, they certainly would not be good options, and neither would anything else that produces undesirable side effects due to their unique pharmacology. If the current options are not cutting it(with the exception of Buprenorphine), we must work to create new, better Opioids. I don't believe Antagonists are a good option either, but this is America, and Uncle Sam is not going to hand out Pharmaceutical Diamorphine to whomever wants it without some kind of insurance plan, unfortunately.
Cane-No problem, anytime. Glad I could help.
Alright, as far as the use of Mixed Agonist Antagonist Opioids for long term maintenence, I still feel that there could be an advantage to their use as opposed to full agonists. The key lies in selectivity, and favorable mu:kappa/sigma ratios. With what I know of Pentazocine and Cyclazocine, they certainly would not be good options, and neither would anything else that produces undesirable side effects due to their unique pharmacology. If the current options are not cutting it(with the exception of Buprenorphine), we must work to create new, better Opioids. I don't believe Antagonists are a good option either, but this is America, and Uncle Sam is not going to hand out Pharmaceutical Diamorphine to whomever wants it without some kind of insurance plan, unfortunately.